Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway
Molecular Nutrition & Food Research · 2024-08 · 68 (16)
DOI: 10.1002/mnfr.202400215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 31.07.2024. Verfasst von Yanhong Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, 030001, China. Hauptthemen laut MEDLINE: Chalcones, NLR Family, Pyrin Domain-Containing 3 Protein, Oxidative Stress, Toll-Like Receptor 4. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: the International Cooperation Projects of Key R&D Programs of the Shanxi Science and Technology Department, the Natural Science Foundation of Shanxi Province, the Shanxi Scholarship Council of China.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is the primary factor that causes chronic kidney disease and causes increasing mortality and morbidity due to its severe consequences. Isoliquiritigenin (ISL) is the primary element of licorice root that is physiologically active and has antifree radical, antioxidation, and antiapoptotic properties. However, the effect of ISL on DKD is still unclear and needs to be further improved. This study aims to evaluate the renoprotective effects of ISL on diabetes‐induced renal injury and explores the underlying mechanisms involved. Male C57BL/6 mice are fed a high‐fat diet and then injected with streptozotocin for 2 consecutive days to establish a diabetic model, and high‐glucose‐treated NRK‐52E cells are used to investigate the renoprotective effects of ISL in DKD. The results show that ISL significantly preserves renal function and architecture in DKD. ISL suppresses oxidative stress and reduces ROS levels, inhibiting the activation of the NF‐κB and the NLRP3 inflammasome and the occurrence of pyroptosis. Moreover, the study finds that ISL can inhibit the mitochondrial apoptotic pathway. In addition, the study confirms the inhibitory effect of ISL on the TLR4/NF‐κB/NLRP3 inflammasome pathway. These observations demonstrate that the natural flavonoid compound ISL can be a promising agent for the treatment of DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
- Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
- Department of Nephrology, Fifth Hospital of Shanxi Medical University, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, 030012, China.
- Department of Nephrology, Third Hospital of Shanxi, Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, 030032, China.
ORCID-Profile: Yanhong Wang, Weiping Fan
Förderung
- the International Cooperation Projects of Key R&D Programs of the Shanxi Science and Technology Department
- the Natural Science Foundation of Shanxi Province
- the Shanxi Scholarship Council of China
- the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province
Zitieren
APA
Wang, Y., Yang, J., Chang, X., Xue, Y., Liu, G., Zhang, T., Chen, W., Fan, W., Tian, J., & Ren, X. (2024). Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway. Molecular Nutrition & Food Research, 68(16). https://doi.org/10.1002/mnfr.202400215
Vancouver
Wang Y, Yang J, Chang X, Xue Y, Liu G, Zhang T, et al. Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway. Molecular Nutrition & Food Research. 2024;68(16). doi:10.1002/mnfr.202400215
BibTeX
@article{Wang2024,
author = {Wang, Yanhong and Yang, Jia and Chang, Xinyue and Xue, Yuan and Liu, Gaohong and Zhang, Tingting and Chen, Weihao and Fan, Weiping and Tian, Jihua and Ren, Xiaojun},
title = {Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway},
journal = {Molecular Nutrition & Food Research},
year = {2024},
volume = {68},
number = {16},
doi = {10.1002/mnfr.202400215}
}
EUVIMED